Literature DB >> 8771194

A model for the regulation of D-3-phosphoglycerate dehydrogenase, a Vmax-type allosteric enzyme.

G A Grant1, D J Schuller, L J Banaszak.   

Abstract

Escherichia coli D-3-phosphoglycerate dehydrogenase (ePGDH) is a tetramer of identical subunits that is allosterically inhibited by L-serine, the end product of its metabolic pathway. Because serine binding affects the velocity of the reaction and not the binding of substrate or cofactor, the enzyme is classified as of the Vmax type. Inhibition by a variety of amino acids and analogues of L-serine indicate that all three functional groups of serine are required for optimal interaction. Removing or altering any one functional group results in an increase in inhibitory concentration from micromolar to millimolar, and removal or alteration of any two functional groups removes all inhibitory ability. Kinetic studies indicate at least two serine-binding sites, but the crystal structure solved in the presence of bound serine and direct serine-binding studies show that there are a total of four serine-binding sites on the enzyme. However, approximately 85% inhibition is attained when only two sites are occupied. The three-dimensional structure of ePGDH shows that the serine-binding sites reside at the interface between regulatory domains of adjacent subunits. Two serine molecules bind at each of the two regulatory domain interfaces in the enzyme. When all four of the serines are bound, 100% inhibition of activity is seen. However, because the domain contacts are symmetrical, the binding of only one serine at each interface is sufficient to produce approximately 85% inhibition. The tethering of the regulatory domains to each other through multiple hydrogen bonds from serine to each subunit apparently prevents the body of these domains from undergoing the reorientation that must accompany a catalytic cycle. It is suggested that part of the conformational change may involve a hinge formed in the vicinity of the union of two antiparallel beta-sheets in the regulatory domains. The tethering function of serine, in turn, appears to prevent the substrate-binding domain from closing the cleft between it and the nucleotide-binding domain, which may be necessary to form a productive hydrophobic environment for hydride transfer. Thus, the structure provides a plausible model that is consistent with the binding and inhibition data and that suggests that catalysis and inhibition in this rare Vmax-type allosteric enzyme is based on the movement of rigid domains about flexible hinges.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8771194      PMCID: PMC2143248          DOI: 10.1002/pro.5560050105

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  16 in total

1.  ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.

Authors:  J MONOD; J WYMAN; J P CHANGEUX
Journal:  J Mol Biol       Date:  1965-05       Impact factor: 5.469

2.  The nucleotide sequence of the serA gene of Escherichia coli and the amino acid sequence of the encoded protein, D-3-phosphoglycerate dehydrogenase.

Authors:  K L Tobey; G A Grant
Journal:  J Biol Chem       Date:  1986-09-15       Impact factor: 5.157

3.  A new family of 2-hydroxyacid dehydrogenases.

Authors:  G A Grant
Journal:  Biochem Biophys Res Commun       Date:  1989-12-29       Impact factor: 3.575

4.  The mechanism of end product inhibition of serine biosynthesis. IV. Subunit structure of phosphoglycerate dehydrogenase and steady state kinetic studies of phosphoglycerate oxidation.

Authors:  I Winicov; L I Pizer
Journal:  J Biol Chem       Date:  1974-03-10       Impact factor: 5.157

5.  The mechanism of end product inhibition of serine biosynthesis. I. Purification and kinetics of phosphoglycerate dehydrogenase.

Authors:  E Sugimoto; L I Pizer
Journal:  J Biol Chem       Date:  1968-05-10       Impact factor: 5.157

6.  The mechanism of end product inhibition of serine biosynthesis. 3. Physical and chemical properties of phosphoglycerate dehydrogenase.

Authors:  J Rosenbloom
Journal:  J Biol Chem       Date:  1968-05-10       Impact factor: 5.157

7.  D-3-phosphoglycerate dehydrogenase from Escherichia coli: isolation by affinity chromatography and sequence comparison to other dehydrogenases.

Authors:  G A Grant; M L Zapp
Journal:  Biosci Rep       Date:  1981-09       Impact factor: 3.840

8.  Transient kinetic and deuterium isotope effect studies on the catalytic mechanism of phosphoglycerate dehydrogenase.

Authors:  R Dubrow; L I Pizer
Journal:  J Biol Chem       Date:  1977-03-10       Impact factor: 5.157

9.  Transient kinetic studies on the allosteric transition of phosphoglycerate dehydrogenase.

Authors:  R Dubrow; L I Pizer
Journal:  J Biol Chem       Date:  1977-03-10       Impact factor: 5.157

10.  Enhanced expression of the Escherichia coli serA gene in a plasmid vector. Purification, crystallization, and preliminary X-ray data of D-3 phosphoglycerate dehydrogenase.

Authors:  D J Schuller; C H Fetter; L J Banaszak; G A Grant
Journal:  J Biol Chem       Date:  1989-02-15       Impact factor: 5.157

View more
  12 in total

1.  The relationship between effector binding and inhibition of activity in D-3-phosphoglycerate dehydrogenase.

Authors:  G A Grant; X L Xu; Z Hu
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  Structure-guided design of a high affinity inhibitor to human CtBP.

Authors:  Brendan J Hilbert; Benjamin L Morris; Keith C Ellis; Janet L Paulsen; Celia A Schiffer; Steven R Grossman; William E Royer
Journal:  ACS Chem Biol       Date:  2015-01-30       Impact factor: 5.100

3.  Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency--a neurometabolic disorder associated with reduced L-serine biosynthesis.

Authors:  L W Klomp; T J de Koning; H E Malingré; E A van Beurden; M Brink; F L Opdam; M Duran; J Jaeken; M Pineda; L Van Maldergem; B T Poll-The; I E van den Berg; R Berger
Journal:  Am J Hum Genet       Date:  2000-10-27       Impact factor: 11.025

4.  5-Aminolevulinic acid production from inexpensive glucose by engineering the C4 pathway in Escherichia coli.

Authors:  Wenwen Ding; Huanjiao Weng; Guocheng Du; Jian Chen; Zhen Kang
Journal:  J Ind Microbiol Biotechnol       Date:  2017-04-05       Impact factor: 3.346

5.  Crystal structure of Mycobacterium tuberculosis LrpA, a leucine-responsive global regulator associated with starvation response.

Authors:  Manchi C M Reddy; Kuppan Gokulan; William R Jacobs; Thomas R Ioerger; James C Sacchettini
Journal:  Protein Sci       Date:  2007-11-27       Impact factor: 6.725

6.  Structural and biochemical analysis of Bacillus anthracis prephenate dehydrogenase reveals an unusual mode of inhibition by tyrosine via the ACT domain.

Authors:  Ivan G Shabalin; Artyom Gritsunov; Jing Hou; Joanna Sławek; Charles D Miks; David R Cooper; Wladek Minor; Dinesh Christendat
Journal:  FEBS J       Date:  2019-12-26       Impact factor: 5.542

7.  Kinetic evidence for interdomain communication in the allosteric regulation of alpha-isopropylmalate synthase from Mycobacterium tuberculosis.

Authors:  Luiz Pedro S de Carvalho; Patrick A Frantom; Argyrides Argyrou; John S Blanchard
Journal:  Biochemistry       Date:  2009-03-10       Impact factor: 3.162

8.  Structural similarity of YbeD protein from Escherichia coli to allosteric regulatory domains.

Authors:  Guennadi Kozlov; Demetra Elias; Anthony Semesi; Adelinda Yee; Miroslaw Cygler; Kalle Gehring
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

9.  Cysteine biosynthesis in Trichomonas vaginalis involves cysteine synthase utilizing O-phosphoserine.

Authors:  Gareth D Westrop; Gordon Goodall; Jeremy C Mottram; Graham H Coombs
Journal:  J Biol Chem       Date:  2006-05-30       Impact factor: 5.157

10.  Three serendipitous pathways in E. coli can bypass a block in pyridoxal-5'-phosphate synthesis.

Authors:  Juhan Kim; Jamie P Kershner; Yehor Novikov; Richard K Shoemaker; Shelley D Copley
Journal:  Mol Syst Biol       Date:  2010-11-30       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.